Drug Type Recombinant polypeptide |
Synonyms- |
Target |
Action modulators |
Mechanism GIPR modulators(Gastric inhibitory polypeptide receptor modulators), GLP-1R modulators(Glucagon-like peptide 1 receptor modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | United States | 01 Aug 2025 | |
| Obesity | Preclinical | United States | 01 Aug 2025 | |
| Metabolic Diseases | Preclinical | United States | 28 Feb 2024 |






